{"nct_id":"NCT03665129","title":"IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors","status":"TERMINATED","status_verified_date":"2022-01","start_date":"2018-09-07","start_date_type":"ACTUAL","primary_completion_date":"2021-02-24","primary_completion_date_type":"ACTUAL","completion_date":"2021-02-24","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["IPHA"]}